2008
DOI: 10.1016/j.cld.2008.07.004
|View full text |Cite
|
Sign up to set email alerts
|

Stellate Cell Contraction: Role, Regulation, and Potential Therapeutic Target

Abstract: SynopsisThe contraction of hepatic stellate cells has been proposed to mediate fibrosis by regulating sinusoidal blood flow and extracellular matrix remodeling. Abundant data from diverse, yet complementary, experimental methods support a robust model for the regulation of contractile force generation by stellate cells. In this model, soluble factors associated with liver injury, including endothelin-1 and nitric oxide, are transduced primarily through rho signaling pathways that promote the myosin IIpowered g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
41
0
1

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(45 citation statements)
references
References 99 publications
3
41
0
1
Order By: Relevance
“…The findings indicate that the activated HSCs in liver fibrosis can be targeted and imaged in vivo by a specific probe when using MR imaging. Since the activated HSCs are responsible for the overproduction of the ECM during the hepatic fibrogenesis, targeting the HSCs is a reasonable option for the cellspecific therapy of liver fibrosis [10,24]. The first HSC-specific carrier, mannose 6-phosphate/ insulin-like growth factorII receptor modified with human serum albumin (M6P/IGFII-HSA), has been reported in 1999 [25].…”
Section: Discussionmentioning
confidence: 99%
“…The findings indicate that the activated HSCs in liver fibrosis can be targeted and imaged in vivo by a specific probe when using MR imaging. Since the activated HSCs are responsible for the overproduction of the ECM during the hepatic fibrogenesis, targeting the HSCs is a reasonable option for the cellspecific therapy of liver fibrosis [10,24]. The first HSC-specific carrier, mannose 6-phosphate/ insulin-like growth factorII receptor modified with human serum albumin (M6P/IGFII-HSA), has been reported in 1999 [25].…”
Section: Discussionmentioning
confidence: 99%
“…Vitamin A storage and metabolism [9] Lipid storage and metabolism [59] Lipid storage and metabolism [41] Vitamin A storage and metabolism [10] Hepatic blood flow regulation [51,58] Endocrine regulation of metabolism [49,64] Tissue repairing [28] Tissue repairing [72] Enzymatic and protein equipment…”
Section: Hsc(s) Adipocytesmentioning
confidence: 99%
“…7 LSECs form a discontinuous barrier without classical TJs and their open fenestrations allow transvascular exchange between blood and the perisinusoidal space of Diss e, which is further populated by Kupffer cells and hepatic stellate cells (HSCs). The latter are considered liver-specific pericytes since several ultrastructural and physiological features of HSCs are similar to those of pericytes in other organs 7,8 : HSCs have long cytoplasmic processes, which embrace the abluminal surface of the endothelium wall surrounding the sinusoids; when activated, they differentiate into myofibroblasts, which express a-smooth muscle actin (a-SMA); and they show vasomotor activity in response to endothelin, angiotensin II or transforming growth factor-b: [9][10][11] Thus, HSCs influence the sinusoid diameter and stabilize vessel walls. The close proximity between LSECs and HSCs allows for paracine signaling via endothelial heparin-binding EGF-like growth factor or platelet derived growth factor-BB (PDGF-BB), which attract HSCs to vessels or via HSC-secreted vascular endothelial growth factor supporting angiogenesis.…”
Section: Introductionmentioning
confidence: 99%